Drug Markets/Acetohydroxamic Acid

Acetohydroxamic Acid

1 NDC across 1 manufacturer|0 Generic,1 Brand

Acetohydroxamic Acid is used to treat urinary tract infections, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on May 31, 1983. In 2024, Medicare Part D spent $651K on Acetohydroxamic Acid across 1,360 claims for 242 beneficiaries.

Acetohydroxamic Acid is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $6.66 to $6.66 per EA. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

1

0G / 1B

Manufacturers

1

competing in market

Price Spread

$6.66 – $6.66

per EA

7d Activity

1 flat

avg +0.0% WoW · of 1 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

1 manufacturer producing ACETOHYDROXAMIC ACID

Drug Portfolio

1 NDCs total, 1 shown

Drug ↕Price 7d Change ↕
LITHOSTAT 250 MG TABLET
$6.6632
per EA
—

Frequently Asked Questions

What is Acetohydroxamic Acid used to treat?

Acetohydroxamic Acid is used to treat urinary tract infections, per the National Library of Medicine's MED-RT classification.

How much does Medicare spend on Acetohydroxamic Acid?

In 2024, Medicare Part D spent $651K on Acetohydroxamic Acid across 1,360 claims for 242 beneficiaries.

How many Acetohydroxamic Acid products are on the market?

The Acetohydroxamic Acid drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.

What is the price range for Acetohydroxamic Acid?

NADAC reference prices for Acetohydroxamic Acid range from $6.6632 to $6.6632 per EA.

Which manufacturers make Acetohydroxamic Acid?

1 manufacturer lists Acetohydroxamic Acid in NADAC. Ranked by number of NDCs, the largest are Mission Pharmacal Company (1).